Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Cancer Chemotherapy and Pharmacology
|
October 18, 2011
Safety and pharmacokinetics of high-dose gefitinib in patients with solid tumors: results of a phase I study
Mitchell E Gross, Lawrence Leichman, Elizabeth S Lowe, et al.
International Journal of Gastrointestinal Cancer
|
September 14, 2004
Phase II clinical trial of 5-fluorouracil, trimetrexate, and leucovorin (NFL) in patients with advanced pancreatic cancer
Agustin A Garcia, Lawrence Leichman, Joaquina Baranda, et al.
Diseases of the Colon and Rectum
|
November 7, 2015
HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy Era
David Grew, Danielle Bitterman, Cynthia G Leichman, et al.
Molecular Cancer Therapeutics
|
July 20, 2019
Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics
In Sil Choi, Shumei Kato, Paul T Fanta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 24, 2018
Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Shumei Kato, Ryosuke Okamura, Joel M Baumgartner, et al.
Cancer Chemotherapy and Pharmacology
|
February 18, 2016
A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Consortium study
Steven J Cohen, Bert H O'Neil, Jordan Berlin, et al.
JCO Precision Oncology
|
April 30, 2019
Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival
Shumei Kato, Maria C Schwaederlé, Paul T Fanta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2011
Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors
Patricia M Lorusso, Antonio Jimeno, Grace Dy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2002
Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer
Nikhil I Khushalani, Cynthia Gail Leichman, Gary Proulx, et al.
The Oncologist
|
September 19, 2025
Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium Study
Deirdre J Cohen, Judith D Goldberg, Lawrence Leichman, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Cancer Chemotherapy and Pharmacology
|
October 18, 2011
Safety and pharmacokinetics of high-dose gefitinib in patients with solid tumors: results of a phase I study
Mitchell E Gross, Lawrence Leichman, Elizabeth S Lowe, et al.
International Journal of Gastrointestinal Cancer
|
September 14, 2004
Phase II clinical trial of 5-fluorouracil, trimetrexate, and leucovorin (NFL) in patients with advanced pancreatic cancer
Agustin A Garcia, Lawrence Leichman, Joaquina Baranda, et al.
Diseases of the Colon and Rectum
|
November 7, 2015
HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy Era
David Grew, Danielle Bitterman, Cynthia G Leichman, et al.
Molecular Cancer Therapeutics
|
July 20, 2019
Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics
In Sil Choi, Shumei Kato, Paul T Fanta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 24, 2018
Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Shumei Kato, Ryosuke Okamura, Joel M Baumgartner, et al.
Cancer Chemotherapy and Pharmacology
|
February 18, 2016
A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Consortium study
Steven J Cohen, Bert H O'Neil, Jordan Berlin, et al.
JCO Precision Oncology
|
April 30, 2019
Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival
Shumei Kato, Maria C Schwaederlé, Paul T Fanta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2011
Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors
Patricia M Lorusso, Antonio Jimeno, Grace Dy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2002
Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer
Nikhil I Khushalani, Cynthia Gail Leichman, Gary Proulx, et al.
The Oncologist
|
September 19, 2025
Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium Study
Deirdre J Cohen, Judith D Goldberg, Lawrence Leichman, et al.
Page
of 3